Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Nancy A. Melville

    News

    Semaglutide Kidney Benefits Extend to Those Without Diabetes

    Author:
    Nancy A. Melville
    Publish date: May 31, 2024

    The kidney benefits observed in patients who are at high risk of kidney disease but do not yet have diabetes or chronic kidney disease is...

    • Read More

    News

    Outside the Guidelines: Prostate Cancer Screening Overused in Older Men

    Author:
    Nancy A. Melville
    Publish date: May 15, 2024

    Experts address potential harms of screening for prostate cancer in patients with low life expectancy.

    • Read More

    News

    Tackling Lean Mass Loss When Weight Loss is Successful

    Author:
    Nancy A. Melville
    Publish date: May 15, 2024

    Clinicians should consider the impact of lean mass loss, not just overall weight loss, when patients lose weight with GLP-1s.

    • Read More

    News

    Kids and Anti-Obesity Medications: Real-World Challenges

    Author:
    Nancy A. Melville
    Publish date: May 10, 2024

    Prescribing anti-obesity medications comes with challenges ranging from accessing and affording the medications...

    • Read More

    News

    What Underlies Sex Differences in CKD Cardiovascular Risk?

    Author:
    Nancy A. Melville
    Publish date: May 6, 2024

    It is important to recognize sex differences in sympathetic nervous activity when assessing cardiovascular risk in CKD.

    • Read More

    News

    Genetic Signatures May Predict CAR T Responders

    Author:
    Nancy A. Melville
    Publish date: April 24, 2024

    Research data suggest that key genetic clues of patients with LBCL could show which are more — or less — likely to respond to axi-cel CAR T.

    • Read More

    News

    Tiny Doses of Metabolically Armed CAR T Show Benefits

    Author:
    Nancy A. Melville
    Publish date: April 23, 2024

    The IL-10-expressing Meta10-19 CAR T-cell therapy improved outcomes in B-ALL and DLBCL at doses 5% and lower of standard CAR T products.

    • Read More

    News

    No Routine Cancer Screening Option? New MCED Tests May Help

    Author:
    Nancy A. Melville
    Publish date: April 15, 2024

    CanScan, MERCURY, and OncoSeek can detect a range of cancers and recognize the tissue of origin with high accuracy.

    • Read More

    News

    Can Sweeteners Improve Weight Maintenance, Overeating?

    Author:
    Nancy A. Melville
    Publish date: March 28, 2024

    Artificial sweeteners may help those trying to keep weight off and aid in reducing overeating, study finds.

    • Read More

    News

    Managing CAR-T Neurotoxicity: EEG Bests the Rest

    Author:
    Nancy A. Melville
    Publish date: March 26, 2024

    In managing the ICANS side effect, electroencephalogram is associated with greater therapeutic intervention versus MRI and lumbar puncture.

    • Read More

    News

    Very Low-Energy Diet Safe, Acceptable for Adolescents

    Author:
    Nancy A. Melville
    Publish date: March 20, 2024

    More research is needed to understand which patients are best suited for the diet.

    • Read More

    News

    Ginger, Cinnamon, Cumin Improve Glycemic Control

    Author:
    Nancy A. Melville
    Publish date: March 19, 2024

    A trio of Mediterranean herbs are linked to fasting glucose impact, finds a meta-analysis.

    • Read More

    News

    Outside the Guidelines: Denosumab Overuse in Prostate Cancer

    Author:
    Nancy A. Melville
    Publish date: March 4, 2024

    For patients with metastatic castration-sensitive disease the bone-modifying agents show no benefit in preventing skeletal-related events, are not...

    • Read More

    News

    Obesity Affects More Than 1 Billion Around the World

    Author:
    Nancy A. Melville
    Publish date: March 4, 2024

    The rate of obesity in adolescents and children increased by 4 times in the past 30 years.

    • Read More

    News

    B-ALL: CAR-T Outperforms Novel Therapies

    Author:
    Nancy A. Melville
    Publish date: March 1, 2024

    Real-world patients with B-ALL who relapsed post transplant showed significantly better outcomes with CAR T-cell therapy versus novel alternative...

    • Read More

    Pages

    • « first
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery